Pharmstandard International S.A. 4
4 · ARGOS THERAPEUTICS INC · Filed Nov 2, 2017
Insider Transaction Report
Form 4
Pharmstandard International S.A.
10% Owner
Transactions
- Other
Common Stock
2017-10-31$795.96/sh−99,495$79,194,040→ 13,142,784 total(indirect: Pharmstandard International S.A. is a wholly owned subsidiary of Joint Stock Company Pharmstandard.)
Footnotes (2)
- [F1]Shares transferred as partial payment pursuant to a service agreement with IBK Company Limited dated 16 September 2016.
- [F2]Pharmstandard International S.A. is a wholly owned subsidiary of Joint Stock Company Pharmstandard. As the parent entity, Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.